Our latest review, 'Current and Emerging Pharmacotherapies for Vascular Malformations', is online. First 50 can download the PDF for free via the link. Thank you, Emmanuel Seront, for putting it together! #VASCAPA #HEVAS #CMTC #VASCERN #RADIOORG #EURORDIS #EVBO #WELRI
https://www.tandfonline.com/eprint/QGPRVVUI8GUT6FQEJFQI/full?target=10.1080/17512433.2026.2641807

What a great #VASCERN-VASCA meeting. Thank you Roberta, Thi-Mai et Treasure for the organisation. And all those having presented the steps made forward in the various task forces. Looking forward to the follow-up of all the action points. #vascapa #hevas #cmtc #vascern #radiorg #eurordis

https://www.facebook.com/100069557370933/videos/pcb.1250340800627821/27316982817890243

VASCERN: The ERN on rare multisystemic vascular diseases on Reels

It was a great annual #Crick #Rare Disease Conference 2026. Learned so much new, made novel contacts, and of course, discussed #precision #therapies for #vascular, and more specifically, #lymphatic anomalies. Organised by @Veronica K. #VASCERN #vascapa #hevas #eurordis #CMTC
The VAS European Book on Angiology/Vascular Medicine (ISBN: 978-3-031-82232-2) is now published accessible in print and online ! #VASCAPA #HEVAS #CMTC #VASCERN #EURORDIS

The Journal of Invest Dermat February cover video https://lnkd.in/eUSWXYFN features #MRI of lower limbs showing #hyperintense slow-flowing blood in dilated veins of the subcutaneous tissues.
Somatic loss-of-function #PIK3R1 and activating non-hotspot PIK3CA mutations associated with Capillary Malformation with #DilatedVeins (CMDV)
https://lnkd.in/e2UAUKJr

A great collaboration with @SalimSeyfried from our #VACure ITN and #Revamp #Leducq networks. Well done Martina. #VASCAPA #HEVAS #CMTC #VASCERN

LinkedIn

This link will take you to a page that’s not on LinkedIn

Congratulations, Emmanuel, on this online publication showing how #sirolimus treatment can be adapted to patients' needs. Most #patients with #slow-#flow #vascular #malformations benefit to some extent, and many experience significant #symptom reduction even with #intermittent dosing. This is a big step forward in the #multimodal management of vascular malformations. #VASCERN #VASCAPA #CMTC #HEVAS #WELRI #ISSVA #EVDays #deduveinstitute #Leducq #Radiorg #Eurordis #Lymph

https://link.springer.com/article/10.1186/s13023-025-04151-y

The virtual #European #Angiology Days (EADays) 2025 are just over. Great presentations and discussions. And easy access - no travel !! Stay tuned for the #EADays – VAS-INT 2026 meeting, which will take place virtually from 27 to 29 November, 2026. #VASCERN #VASCA #VASCAPA #HEVAS #CMTC #EURORDIS #ISSVA #NAVBO #EVBO
Congratulations to all three young investigators who received the 1st International Joint Young Investigator/Clinician Awards in #Vascular #Medicine during the virtual #European #Angiology Days (EADays) 2025 event: Dr #Annegret Holm , Dr Jennilyn Mangulabnan, and Dr Julie Anne Miralles-Amora. Stay tuned for the #EADays – VAS-INT 2026 meeting, which will take place virtually from 27 to 29 November, 2026. #VASCERN #VASCA #VASCAPA #HEVAS #CMTC #EURORDIS #ISSVA #NAVBO #EVBO
So great 2 days at the #French Society of #Lymphology 2025 in Toulouse on lymphatic malformations, lymphoedema and lipedema. Illustrative presentations, pertinent questions and collegial discussions. The field is moving along faster than ever. Humbling to be part of the faculty. #vascapa #hevas #CMTC #Welbio #eshg #revamp #VASCERN #eurordis #Radiorg #lymph #LM #ISSVA
What a great session at the #BRAIN 2025 in London on fast-flow vascular malformations in the brain. Intense discussions and data sharing. Humbling to be part of the faculty. #vascapa #hevas #CMTC #Welbio #eshg #revamp #VASCERN #eurordis #Radiorg